… detects and counts protein clumps; sFIDA) assay for the diagnosis of prion (infectious) diseases at the Institute of … 2013, Bannach has led the sFIDA diagnostics group at the research Centre Jülich. His research is committed to the development of platform …

… gastrointestinal system in previous clinical trials, but early pre-clinical work into XenoPort’s drug has found these effects to be reduced. …

… across the industry. Mark Frasier , PhD, vice president of research programs at MJFF , is at the Pharmaceutical … and Research . Stay tuned to this space for further insight into what TransCelerate could mean for speeding new … year-end goal of 10,000 registered volunteers - four months early. MJFF now has a new goal: to get to 15,000 by year’s …

… When my neurologist diagnosed me in 2018 at age 57, she told me that vigorous exercise was the best therapy for my Parkinson’s disease (PD).    I took that to heart. Though I have … of them were not easy to get into. I had an accomplice, however. (Maybe enabler is a better term.) Team Fox of The …

… A drug that may slow or stop Parkinson’s disease is moving into later-stage trials and closer to patient hands after a … PhD, Michael J. Fox Foundation (MJFF) Vice President of Research Programs. “Our Foundation has ushered this research … inhibitors may work for a broader disease population. But early development of this drug class pointed to some safety …

… and the Power of Art (Ask the MD Video) Parkinson's Research News New Global Research Effort Aims to Accelerate Progress in… Foundation … members worldwide are turning their passions and interests into millions in funding for Parkinson's research. Join an …